missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ HS3ST1 Polyclonal Antibody

Description
Reconstitute in sterile PBS to a final concentration of 0.2 mg/mL.
HS3ST1 is the rate limiting enzyme for synthesis of HSact. HS3ST1 performs the crucial step modification in the biosynthesis of anticoagulant heparan sulfate (HSact) that is to complete the structure of the antithrombin pentasaccharide binding site. Heparan sulfate biosynthetic enzymes are key components in generating a myriad of distinct heparan sulfate fine structures that carry out multiple biologic activities. The enzyme encoded by this gene is a member of the heparan sulfate biosynthetic enzyme family. It possesses both heparan sulfate glucosaminyl 3-O-sulfotransferase activity, anticoagulant heparan sulfate conversion activity, and is a rate limiting enzyme for synthesis of anticoagulant heparan. This enzyme is an intraluminal Golgi resident protein.
Specifications
Specifications
| Antigen | HS3ST1 |
| Applications | Immunoprecipitation, Western Blot |
| Classification | Polyclonal |
| Concentration | 0.2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 5% trehalose and No Preservative |
| Gene | HS3ST1 |
| Gene Accession No. | O14792 |
| Gene Alias | 3OST; 3-Ost; 3OST1; 3-OST-1; D5Wsu110e; h3-OST-1; heparan sulfate; heparan sulfate (glucosamine) 3-O-sulfotransferase 1; heparan sulfate 3-O-sulfotransferase 1; heparan sulfate 3-O-sulfotransferase-1; heparan sulfate 3-O-sulfotransferase-1 precursor; heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1; Heparan sulfate glucosamine 3-O-sulfotransferase 1; heparan sulfate-glucosamine 3-sulfotransferase 1; heparin-glucosamine 3-O-sulfotransferase; HS3ST1; Hsg3ost |
| Gene Symbols | HS3ST1 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?